Creation of polyclonal antibody of secreted protein SEPINE2, which is expressed in testicular cancer cell line with high metastatic potential. How does it work in testicular cancer metastasis?
Creation of polyclonal antibody of secreted protein SEPINE2, which is expressed in testicular cancer cell line with high metastatic potential. How does it work in testicular cancer metastasis?
创建分泌蛋白 SEPINE2 的多克隆抗体，该蛋白在具有高转移潜力的睾丸癌细胞系中表达。
批准号：
22890108
负责人：
NAGAHARA Akira
金额：
$1.96万
依托单位：
依托单位国家：
日本
项目类别：
Grant-in-Aid for Research Activity Start-up
财政年份：
2010
资助国家：
日本
项目状态：
已结题
起止时间：
2010 至 2011
中文摘要
翻译
我们试图建立一个多克隆抗体的分泌蛋白SERPINE 2，我们已经报道，并阐明如何在睾丸癌转移。虽然我们建立了稳定表达SERPINE2的睾丸癌细胞系，但在体内和临床标本中均未得到SERPINE2是转移启动子的证据。遗憾的是，我们研制出了SERPINE2的抗体。
英文摘要
We tried to create a polyclonal antibody of secreted protein SERPINE2 that we had reported before and to elucidate how it work in testicular cancer metastasis. Although we established stable SERPINE-expressed testicular cancer cell line, we couldn' t get evidence that SERPINE2 was metastatic promoter in vivo and mRNA expression analysis in clinical samples. And we regretted to create the antibody of SERPINE2.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
